Pershing Square No Longer Holds A Position In Zoetis

Loading...
Loading...
Billionaire investor
Bill Ackmanacquired
an approximate 8.5 percent stake in
Zoetis IncZTS
, a producer of animal medicines and vaccinations, back in November 2014.

Ackman and his hedge fund Pershing Square Capital Management first bought 5.5 million shares of Zoetis in 2014 at $34 per share and added to his position over the years. The New York Times reported in May of this year that Ackman was looking to sell its entire 16.85 million share stake in Zoetis for a price range of $46.75 to $47 per share or a total consideration of around $800 million.

The New York times also noted that Ackman paid $1.5 billion for the entire stake of Zoetis.

Zoetis' stock was trading at $51.02 on Thursday.

Pershing Eliminates Its Stake

Pershing Square confirmed with Benzinga on Thursday that Ackman announced during the fund's quarterly investor call that it completed sold its stake in Zoetis.

Market News and Data brought to you by Benzinga APIs
Posted In: BiotechNewsHedge FundsAsset SalesGeneralBill AckmanBill Ackman ZoetisNew York TimesPershing Square Capital Management
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...